Blood eosinophils, fraction of exhaled nitric oxide, and serum eosinophil cationic protein as surrogate markers for sputum eosinophils in asthma: influence of treatment with inhaled corticosteroids

Alvarez Puebla, MJ; Aroabarren Aleman, E; Corcuera Garcia, A; Ibañez Bereiz, B; Iraola Iribar, A; Olaguibel Rivera, JM.
J. investig. allergol. clin. immunol ; 28(3): 210-212, 2018. tab
Artículo en Inglés | IBECS (España) | ID: ibc-174465

Documentos relacionados

  1. Relationship of mannitol challenge to methacholine challenge and inflammatory markers in persistent asthmatics receiving inhaled corticosteroids.
  2. Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
  3. Exhaled nitric oxide is associated with allergic inflammation in children.
  4. Small airway dysfunction in patients with cough variant asthma: a retrospective cohort study.
  5. Low sputum eosinophils predict the lack of response to beclomethasone in symptomatic asthmatic patients.
  6. Home and day-care microenvironment exposure to Blomia tropicalis allergens and their associations with salivary eosinophilic cationic protein (ECP) among preschool children in Singapore.
  7. Predictors of response to therapy with omalizumab in patients with severe allergic asthma - a real life study.
  8. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
  9. Eosinophil activity in infants hospitalized for wheezing and risk of persistent childhood asthma.
  10. Identifying the components of asthma health status in children with mild to moderate asthma.